Login / Signup

Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

Céline CallensDominique VaurIsabelle SoubeyranEtienne RouleauPierre-Alexandre JustErell GuillermLisa GolmardNicolas GoardonNicolas SevenetOdile CabaretPhilipp HarterAntonio Gonzalez-MartinKeiichi FujiwaraSabrina Chiara CecereNicoletta ColomboChristian MarthIgnace VergoteJohanna MaenpaaEric Pujade-LauraineIsabelle L Ray-Coquard
Published in: Journal of the National Cancer Institute (2022)
tBRCA testing is an appropriate tool with an acceptable turnaround time for clinical practice and a low failure rate, ensuring reliable identification of patients likely to benefit from poly(ADP-ribose) polymerase inhibitor therapy.
Keyphrases